Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership836,544 shares
Latest Disclosed Value $ 24,853,723
D. E. Shaw & Co., Inc. ownership in TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 836,544 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $24,853,722 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,094,556 shares of Travere Therapeutics, Inc.. This represents a change in shares of -23.57% during the quarter. The current value of the position is $37,811,789 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 836,544 -258,012 -23.57 24,854 -40.57 0.0149
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,094,556 431,304 65.03 41,823 163.84 0.0229
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 663,252 -467,498 -41.34 15,852 -5.28 0.0089
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,130,750 -582,842 -34.01 16,735 -45.50 0.0119
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,713,592 -564,783 -24.79 30,708 -22.63 0.0273
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 2,278,375 438,306 23.82 39,689 54.18 0.0291
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,840,069 306,997 20.02 25,743 104.29 0.0221
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,533,072 -311,591 -16.89 12,602 -11.40 0.0118
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,844,663 186,516 11.25 14,222 -4.59 0.0122
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,658,147 674,602 68.59 14,907 69.54 0.0130
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 983,545 -277,459 -22.00 8,793 -54.61 0.0092
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,261,004 261,513 26.16 19,369 -13.83 0.0198
2023-05-15 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 999,491 532,651 114.10 22,479 128.97 0.0241
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 466,840 90,997 24.21 9,818 6.00 0.0109
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 375,843 -52,984 -12.36 9,261 -10.87 0.0111
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 428,827 -46,574 -9.80 10,390 -15.19 0.0122
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 475,401 128,060 36.87 12,251 13.64 0.0115
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 347,341 -58,496 -14.41 10,781 9.55 0.0089
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 405,837 -791,961 -66.12 9,841 -43.69 0.0089
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,197,798 -278,681 -18.87 17,476 -52.60 0.0151
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,476,479 -67,363 -4.36 36,868 -12.38 0.0356
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,543,842 -109,196 -6.61 42,077 37.89 0.0376
2020-11-16 2020-09-30 13F RETROPHIN COM 761299106 1,653,038 -130,094 -7.30 30,515 -16.15 0.0312
2020-08-14 2020-06-30 13F RETROPHIN COM 761299106 1,783,132 196,601 12.39 36,394 57.22 0.0434
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 1,586,531 143,959 9.98 23,148 13.00 0.0361
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 1,442,572 298,532 26.09 20,485 54.49 0.0234
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 1,144,040 252,373 28.30 13,260 -25.98 0.0163
2019-08-14 2019-06-30 13F RETROPHIN COM 761299106 891,667 33,078 3.85 17,914 -7.80 0.0223
2019-05-15 2019-03-31 13F RETROPHIN COM 761299106 858,589 81,069 10.43 19,430 10.43 0.0251
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 777,520 182,318 30.63 17,595 2.89 0.0242
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 595,202 76,174 14.68 17,101 20.87 0.0205
2018-08-14 2018-06-30 13F RETROPHIN COM 761299106 519,028 119,500 29.91 14,148 58.36 0.0185
2018-05-15 2018-03-31 13F RETROPHIN COM 761299106 399,528 104,586 35.46 8,934 43.77 0.0122
2018-02-14 2017-12-31 13F RETROPHIN COM 761299106 294,942 135,761 85.29 6,214 56.84 0.0086
2017-11-14 2017-09-30 13F RETROPHIN COM 761299106 159,181 117,425 281.22 3,962 389.74 0.0061
2017-08-14 2017-06-30 13F RETROPHIN COM 761299106 41,756 -46,503 -52.69 809 -50.34 0.0013
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 88,259 30,540 52.91 1,629 49.04 0.0029
2017-02-14 2016-12-31 13F RETROPHIN COM 761299106 57,719 23,219 67.30 1,093 41.58 0.0019
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 34,500 -9,686 -21.92 772 -1.91 0.0014
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 44,186 16,577 60.04 787 108.75 0.0015
2016-05-16 2016-03-31 13F RETROPHIN COM 761299106 27,609 27,609 0.00 377 0.0007
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 0 -33,619 -100.00 0 -100.00
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 33,619 -6,081 -15.32 1,114 17.14 0.0017
2015-05-15 2015-03-31 13F RETROPHIN COM 761299106 39,700 -5,900 -12.94 951 70.43 0.0015
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 45,600 24,200 113.08 558 189.12 0.0007
2014-11-14 2014-09-30 13F RETROPHIN COM 761299106 21,400 7,600 55.07 193 19.14 0.0002
2014-08-14 2014-06-30 13F RETROPHIN COM 761299106 13,800 3,665 36.16 162 -25.00 0.0002
2014-05-15 2014-03-31 13F RETROPHIN COM 761299106 10,135 10,135 216 0.0003
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F RETROPHIN COM Put 20,000 0.00 421 -15.46 n/a n/a n/a
2017-11-14 2017-09-30 13F RETROPHIN COM Put 20,000 0.00 498 28.35 n/a n/a n/a
2017-08-14 2017-06-30 13F RETROPHIN COM Put 20,000 0.00 388 5.15 n/a n/a n/a
2017-05-15 2017-03-31 13F RETROPHIN COM Put 20,000 -66.67 369 -67.52 n/a n/a n/a
2017-02-14 2016-12-31 13F RETROPHIN COM Put 60,000 0.00 1,136 -15.41 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Put 60,000 0.00 1,343 25.63 n/a n/a n/a
2016-08-15 2016-06-30 13F RETROPHIN COM Put 60,000 20.00 1,069 56.52 n/a n/a n/a
2016-05-16 2016-03-31 13F RETROPHIN COM Put 50,000 683 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.